简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-11-10 11:35 Organon Announces Agreement to Divest its JADA® System for Up to $465 Million to Laborie
2025-11-10 10:51 Takeda Presents New Data Showing Mezagitamab (TAK-079) Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy
2025-11-10 10:28 BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates
2025-11-07 19:02 NJ Bio Bridges the Translation Research Gap with the Asset Purchase and Integration of L2P® Services
2025-11-07 10:58 BOSTON ONCOLOGY ARABIA and LOCAL CONTENT & GOVERNMENT PROCUREMENT AUTHORITY Sign Agreement to Localize Advanced Biologic Medicines in Saudi Arabia
2025-11-06 15:20 Registrar Corp Acquires CMC Medical Devices to Make Global Compliance Quick and Easy
2025-11-05 14:06 Galderma Receives U.S. FDA Approval for Restylane® Lyft™ for the Enhancement of the Chin Profile
2025-11-04 16:50 Newly Established Samsung Epis Holdings to Drive Growth for Samsung Bioepis and a New Subsidiary
2025-11-04 10:09 New Phase 3 Data Show Takeda’s Dengue Vaccine Delivers 7 Years of Sustained Protection Against Infection and Hospitalization
2025-10-31 14:45 IFF Honors Distinguished Academics Shaping the Future of Nutrition, Health and Biosciences
2025-10-31 12:36 Crown Bioscience Achieves Second CLIA Certification of 2025 at Suzhou Laboratory
2025-10-31 11:38 Novotech Maps Global Growth in Radiopharmaceutical Trials
2025-10-30 15:14 Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filings This Fiscal Year
2025-10-30 10:25 Swiss Rockets Announces Strategic Exclusive License Acquisition of Cutting-Edge Sequencing Technology from MGI Tech and Complete Genomics
2025-10-30 10:23 Ferring Pharmaceuticals to Explore Strategic Options for Rebyota®
2025-10-28 15:03 Pacific Prime Released State of Health Insurance Report 2025
2025-10-28 10:27 Colorectal, Liver, and Lung Cancer Patients at Vinmec Experience Extended Survival with AIET Cell-Based Immunotherapy – Technology Transferred from Japan
2025-10-27 15:16 Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital
2025-10-27 13:39 SINOVAC Announces Appointment of Independent Auditor
2025-10-27 12:30 Berry Consultants Releases FACTS 8 Clinical Trial Simulator

Business Wire Weibo

Press Releases

Latest Releases